Advertisement

Médecine Intensive Réanimation

, Volume 26, Issue 6, pp 523–527 | Cite as

Myocardite aiguë fulminante chez une femme enceinte traitée par assistance circulatoire

  • W. SellamiEmail author
  • Z. Hajjej
  • M. Ferjani
Cas Clinique Commenté / Commented Case Report
  • 231 Downloads

Résumé

La myocardite fulminante est une inflammation rare affectant l’adulte relativement jeune. Nous rapportons un cas de femme enceinte de 29 ans présentant de façon brutale en périopératoire un tableau d’insuffisance cardiaque sévère en rapport avec une myocardite fulminante aiguë dont le bilan étiologique était négatif. Un traitement à base de lévosimendan associé à une assistance circulatoire par ECMO a permis une récupération partielle de la fonction systolique de ventricule gauche dans les deux semaines postopératoires.

Mots clés

Choc cardiogénique Myocardite fulminante Grossesse 

Fulminant acute myocarditis in a pregnant woman treated with circulatory assistance

Abstract

Fulminant myocarditis is a rare inflammatory affecting relatively young adult. We report a case of 29- year-old pregnant woman with an acute intraoperative onset of a severe heart failure. A rapid and accurate diagnostic approach suggested an acute fulminant myocarditis. Initial hemodynamic support without immunosuppressive and viral therapy resulted in a partial recovery within a two week. Patients presenting with acute fulminant myocarditis with unknown etiology can have a complete recovery with an appropriate and rapid timing of an aggressive hemodynamic support including levosimendan and extracorporeal membrane oxygenation.

Keywords

Cardiogenic shock Fulminant myocarditis Pregnancy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Teele SA, Allan CK, Laussen PC, Newburger JW, Gauvreau K, Thiagarajan RR, (2011) Management and outcomes in pediatric patients presenting with acute fulminant myocarditis. J Pediatr 158: 638–643CrossRefPubMedGoogle Scholar
  2. 2.
    McCarthy RE, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342: 690–695CrossRefPubMedGoogle Scholar
  3. 3.
    Cooper LT, (2009) Myocarditis. N Engl J Med 360: 1526–1538CrossRefPubMedGoogle Scholar
  4. 4.
    Hékimian G, Franchineau G, Bréchot N, Schmidt M, Nieszkowska A, Besst S, Luyt CE, Combes A, (2017) Diagnostic et prise en charge des myocardites. Med Intensive Rea 26: 196–206Google Scholar
  5. 5.
    Sagar S, Liu PP, Cooper LT Jr, (2012) Myocarditis. Lancet 379: 738–747CrossRefPubMedGoogle Scholar
  6. 6.
    Wheeler DS, Kooy NW, (2003) A formidable challenge: the diagnosis and treatment of viral myocarditis in children. Crit Care Clin 19: 365–391CrossRefPubMedGoogle Scholar
  7. 7.
    Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, Klingel K, Kandolf R, Sechtem U, Cooper LT, Böhm M, (2012) Update on myocarditis. J Am Coll Cardiol 59: 779–792CrossRefPubMedGoogle Scholar
  8. 8.
    Leone O, Veinot JP, Angelini A, Baandrup UT, Basso C, Berry G, Bruneval P, Burke M, Butany J, Calabrese F, d’Amati G, Edwards WD, Fallon JT, Fishbein MC, Gallagher PJ, Hallushka MK, McManus B, Pucci A, Rodriguez ER, Saffitz JE, Sheppard MN, Steenbergen C, Stone JR, Tan C, Thiene G, van der Wal AC, Winters GL, (2012) Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardio Vasc Pathol 21: 245–274CrossRefGoogle Scholar
  9. 9.
    Ergaz Z, Omoy A, (2006) Parvorius B 19 in pregnancy. Reprod Toxicol 21:421–35CrossRefPubMedGoogle Scholar
  10. 10.
    Doltra A, Amundsen BH, Gebker R, Fleck E, Kelle S, (2013) Emerging concepts for myocardial late gadolinium enhancement MRI. Curr Cardiol Rev 9: 185–190CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, (2009) Cardiovascular magneticresonance in myocarditis: a JACC white paper. J Am Coll Cardiol 53: 1475–1487CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Dennert R, Velthuis S, Westermann D, Donker D, Schalla S, van Suylen RJ, Heymans S, (2010) Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy. Antivir Ther 15: 681–685CrossRefPubMedGoogle Scholar
  13. 13.
    Mebazaa A, Tolppanen H, Mueller C, Lassus J, DiSomma S, Baksyte G, Cecconi M, Choi DJ, Cohen Solal A, Christ M, Masip J, Arrigo M, Nouira S, Ojji D, Peacock F, Richards M, Sato N, Sliwa K, Spinar J, Thiele H, Yilmaz MB, Januzzi J, (2016) Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive Care Med 42: 147–163CrossRefPubMedGoogle Scholar
  14. 14.
    Asaumi Y, Yasuda S, Morii I, (2005) Favorable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Eur Heart J 26: 2185–2192CrossRefPubMedGoogle Scholar
  15. 15.
    Pages ON, Aubert S, Combes A, Luyt CE, Pavie A, Léger P, Gandjbakhch I, Leprince P, (2009) Paracorporeal pulsatile biventricular assist device versusextracorporal membrane oxygenationextracorporal life support in adult fulminant myocarditis. J Thorac Cardiovasc Surg 137: 194–197CrossRefPubMedGoogle Scholar
  16. 16.
    Maisch B, Hufnagel G, Kölsch S, Funck R, Richter A, Rupp H, Herzum M, Pankuweit S, (2004) Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Herz 29: 624–636CrossRefPubMedGoogle Scholar

Copyright information

© Société de réanimation de langue française (SRLF) et Lavoisier 2017

Authors and Affiliations

  1. 1.Département d’anesthésie réanimationhôpital militaire principal d’instruction de TunisMontefleury, TunisTunisie
  2. 2.Université El-ManarTunisTunisie

Personalised recommendations